20.26 USD
↘ 0.29 (1.41%)LIVE (AS OF 12:32 PM EDT)
Avalo Therapeutics, Inc. Common Stock
AVTXNASDAQ • USD
Market: OPEN
Shares of Avalo Therapeutics, Inc. Common Stock (AVTX) are trading at $20.26. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics place AVTX at a fair price relative to peers.
Technical & fundamental data as of Aug 26, 2026.
Open?$20.47
High?$20.77
Low?$19.96
Prev. Close?$20.55
Volume?92.0K
Avg. Volume?803.7K
VWAP?$20.23
Rel. Volume?0.11x
Bid / Ask
Bid?$20.24 × 100
Ask?$20.30 × 100
Spread?$0.06
Midpoint?$20.27
Valuation & Ratios
Market Cap?1.1B
Shares Out?53.6M
Float?51.8M
Float %?96.6%
P/E Ratio?N/A
P/B Ratio?2.46
EPS?-$1.87
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
Address
1500 LIBERTY RIDGE DRIVE
WAYNE, PA 19087
Phone: 410-522-8707
WAYNE, PA 19087
Phone: 410-522-8707
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?30
Piotroski F-Score?0/9Weak
Altman Z-Score?14.59Safe
Confidence?48%Low
Short InterestSqueeze Risk
Short % of Float?25.27%Squeeze Risk
Short Interest?13.1M
Days to Cover?20.2
Free Float51.8M
Avg Daily Volume647.1K
Settlement Date2026-08-14
Financial Health
Current Ratio?19.31Strong
Quick Ratio?19.31Strong
Cash Ratio?4.04Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?2.46CHEAP▾
Peers100
S&P65
P/S?18,679.60HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-11.1CHEAP▾
S&P97
EV/Sales?17,232.45HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-22.4%WEAK▾
S&P7
ROA?-20.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-68290000
Enterprise Value?$1.0B
Fundamentals ratios updated end of day